Technavio has been monitoring the POC HbA1C testing market and it is poised to grow by USD 203.16 million during 2020-2024, progressing at a CAGR of almost 9% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200521005638/en/
Technavio has announced its latest market research report titled Global POC HbA1C Testing Market 2020-2024 (Graphic: Business Wire)
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request Free Sample Report on COVID-19 Impact
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corp., EKF Diagnostics Holdings Plc, F. Hoffmann-La Roche Ltd, HUMAN Gesellschaft für Biochemica und Diagnostica mbH, OSANG Healthcare, Quest Diagnostics Inc., Siemens Healthineers AG, and Tosoh Corp. are some of the major market participants. The rise in the prevalence of diabetes will offer immense growth opportunities. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Rise in the prevalence of diabetes has been instrumental in driving the growth of the market.
POC HbA1C Testing Market 2020-2024: Segmentation
POC HbA1C Testing Market is segmented as below:
- Geographic Landscape
- North America
To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43174
POC HbA1C Testing Market 2020-2024: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our POC HbA1C testing market report covers the following areas:
- POC HbA1C Testing Market Size
- POC HbA1C Testing Market Trends
- POC HbA1C Testing Market Industry Analysis
This study identifies the increasing equipment rental agreements as one of the prime reasons driving the POC HbA1C testing market growth during the next few years.
POC HbA1C Testing Market 2020-2024: Vendor Analysis
We provide a detailed analysis of vendors operating in the POC HbA1C testing market, including some of the vendors such as Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corp., EKF Diagnostics Holdings Plc, F. Hoffmann-La Roche Ltd, HUMAN Gesellschaft für Biochemica und Diagnostica mbH, OSANG Healthcare, Quest Diagnostics Inc., Siemens Healthineers AG, and Tosoh Corp. Backed with competitive intelligence and benchmarking, our research reports on the POC HbA1C testing market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
Register for a free trial today and gain instant access to 17,000+ market research reports.
POC HbA1C Testing Market 2020-2024: Key Highlights
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will assist POC HbA1C testing market growth during the next five years
- Estimation of the POC HbA1C testing market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the POC HbA1C testing market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of POC HbA1C testing market vendors
Table Of Contents:
- Market Overview
- Market ecosystem
- Value chain analysis
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Consumables - Market size and forecast 2019-2024
- Instruments - Market size and forecast 2019-2024
- Market opportunity by Product
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- APAC - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
Drivers, Challenges, and Trends
- Landscape disruption
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- EKF Diagnostics Holdings Plc
- F. Hoffmann-La Roche Ltd
- HUMAN Gesellschaft für Biochemica und Diagnostica mbH
- OSANG Healthcare
- Quest Diagnostics Inc.
- Siemens Healthineers AG
- Tosoh Corp.
- Scope of the report
- Currency conversion rates for US$
- Research methodology
List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.